|
Probiotics in Pulmonaty Rehabilitation for COPD
RECRUITINGN/ASponsored by Fu Jen Catholic University
Actively Recruiting
PhaseN/A
SponsorFu Jen Catholic University
Started2024-12-05
Est. completion2026-12-31
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06717659
Summary
This study aims to investigate various aspects of patients with chronic respiratory diseases undergoing pulmonary rehabilitation supplemented with probiotics. The focus will be on clinical physiological responses, functional performance, respiratory status assessments, nutritional status evaluations, body composition analyses, and biochemical blood parameters, with a primary emphasis on the anti-inflammatory response.
Eligibility
Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria: * Willing to sign a written informed consent form. * Diagnosed with pre-COPD or COPD stage I-IV according to the 2023 GOLD guidelines. * Undergoing pulmonary rehabilitation therapy for more than three months. Exclusion Criteria: * Under 18 years old. * Diagnosed with neuromuscular diseases. * Experienced respiratory disease exacerbation requiring emergency care or hospitalization in the past three months. * Unable to cooperate with cardiopulmonary exercise testing. * Has other diseases or behavioral restrictions preventing participation in exercise training for over one year. * Assessed by a physician to have severe malnutrition or a significantly low BMI.
Conditions4
Body Composition MeasurementCOPDCOPD - Chronic Obstructive Pulmonary DiseaseProbiotic Intervention
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorFu Jen Catholic University
Started2024-12-05
Est. completion2026-12-31
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06717659